Pharma Co. Sued In Del. For Docs On Undisclosed IP Value
A Silver Creek Pharmaceuticals shareholder has sued the clinical stage biotech in Delaware's Court of Chancery, claiming that since its CEO resigned in December 2020, the company has stopped communicating to...To view the full article, register now.
Already a subscriber? Click here to view full article